- Home
- NWL vs IDYA Comparison
NWL vs IDYA Comparison
Compare NWL & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- IDYA
- Stock Information
- Founded
- NWL 1903
- IDYA 2015
- Country
- NWL United States
- IDYA United States
- Employees
- NWL N/A
- IDYA N/A
- Industry
- NWL Plastic Products
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- NWL Industrials
- IDYA Health Care
- Exchange
- NWL Nasdaq
- IDYA Nasdaq
- Market Cap
- NWL 2.1B
- IDYA 2.3B
- IPO Year
- NWL N/A
- IDYA 2019
- Fundamental
- Price
- NWL $3.22
- IDYA $29.66
- Analyst Decision
- NWL Buy
- IDYA Buy
- Analyst Count
- NWL 8
- IDYA 15
- Target Price
- NWL $6.06
- IDYA $47.69
- AVG Volume (30 Days)
- NWL 11.4M
- IDYA 1.3M
- Earning Date
- NWL 10-31-2025
- IDYA 11-04-2025
- Dividend Yield
- NWL 8.70%
- IDYA N/A
- EPS Growth
- NWL N/A
- IDYA N/A
- EPS
- NWL N/A
- IDYA N/A
- Revenue
- NWL $7,256,000,000.00
- IDYA $214,834,000.00
- Revenue This Year
- NWL N/A
- IDYA $90.17
- Revenue Next Year
- NWL $1.37
- IDYA $217.29
- P/E Ratio
- NWL N/A
- IDYA N/A
- Revenue Growth
- NWL N/A
- IDYA 5377.66
- 52 Week Low
- NWL $3.07
- IDYA $13.45
- 52 Week High
- NWL $11.78
- IDYA $33.64
- Technical
- Relative Strength Index (RSI)
- NWL 17.47
- IDYA 52.14
- Support Level
- NWL $3.07
- IDYA $28.17
- Resistance Level
- NWL $5.14
- IDYA $33.64
- Average True Range (ATR)
- NWL 0.20
- IDYA 1.66
- MACD
- NWL -0.18
- IDYA -0.10
- Stochastic Oscillator
- NWL 7.25
- IDYA 41.04
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.